APA
Barbour A. P., Walpole E. T., Mai G. T., Barnes E. H., Watson D. I., Ackland S. P., Martin J. M., Burge M., Finch R., Karapetis C. S., Shannon J., Nott L. M., Varma S., Marx G., Falk G. L., Gebski V., Oostendorp M., Wilson K., Thomas J., Lampe G., Zalcberg J. R., Simes J. & Smithers B. M. (20210106). Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Barbour A P, Walpole E T, Mai G T, Barnes E H, Watson D I, Ackland S P, Martin J M, Burge M, Finch R, Karapetis C S, Shannon J, Nott L M, Varma S, Marx G, Falk G L, Gebski V, Oostendorp M, Wilson K, Thomas J, Lampe G, Zalcberg J R, Simes J and Smithers B M. 20210106. Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Barbour A. P., Walpole E. T., Mai G. T., Barnes E. H., Watson D. I., Ackland S. P., Martin J. M., Burge M., Finch R., Karapetis C. S., Shannon J., Nott L. M., Varma S., Marx G., Falk G. L., Gebski V., Oostendorp M., Wilson K., Thomas J., Lampe G., Zalcberg J. R., Simes J. and Smithers B. M. (20210106). Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Barbour A P, Walpole E T, Mai G T, Barnes E H, Watson D I, Ackland S P, Martin J M, Burge M, Finch R, Karapetis C S, Shannon J, Nott L M, Varma S, Marx G, Falk G L, Gebski V, Oostendorp M, Wilson K, Thomas J, Lampe G, Zalcberg J R, Simes J and Smithers B M. Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20210106.